Needham Maintains Buy on Doximity, Lowers Price Target to $27

Benzinga Newsdesk www.benzinga.com Negative 52.6%

Neg 52.6% Neu 0% Pos 0%

Needham analyst Ryan MacDonald maintains Doximity (NYSE:DOCS) with a Buy and lowers the price target from $55 to $27.

Comments

No comments yet. Be the first!